Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial

Katherine L. Pogue-Geile, Nan Song, Jong Hyeon Jeong, Patrick G. Gavin, Seong Rim Kim, Nicole L. Blackmon, Melanie Finnigan, Priya Rastogi, Louis Fehrenbacher, Eleftherios P. Mamounas, Sandra M. Swain, D. Lawrence Wickerham, Charles E. Geyer, Joseph P. Costantino, Norman Wolmark, Soonmyung Paik

Research output: Contribution to journalArticlepeer-review

90 Scopus citations

Fingerprint

Dive into the research topics of 'Intrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences